Home/Filings/4/0001140361-25-007181
4//SEC Filing

Hagen Heidi 4

Accession 0001140361-25-007181

CIK 0000887359other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:05 PM ET

Size

8.5 KB

Accession

0001140361-25-007181

Insider Transaction Report

Form 4
Period: 2025-03-03
Hagen Heidi
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-03$3.74/sh+9,000$33,66037,650 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-03-03+9,0000 total
    Exercise: $3.74Common Stock (9,000 underlying)
  • Sale

    Common Stock

    2025-03-03$49.53/sh9,000$445,77028,650 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
  • [F2]These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
  • [F3]These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001585084

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:05 PM ET
Size
8.5 KB